Verastem Presents New Data on Mesothelioma Programs at the 12th...

Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the presentation of clinical and preclinical data in oral presentation and discussion sessions at the 12th International Mesothelioma Interest Group Conference being held October 22-24, 2014, at the Cape Town International Conference Centre in Cape Town, South Africa.

http://ift.tt/1D5TOHl